Development of the Nanobody display technology to target lentiviral...

Correspondence: Professor K Breckpot, Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.

http://www.nature.com/gt/journal/v19/n12/full/gt2011206a.html